ATAI Life Sciences N.V (NASDAQ: ATAI) Now Carries A 12-Month Price Target Of $5.
ATAI Life Sciences N.V (NASDAQ:ATAI)’s traded shares stood at 1.23 million during the last session, with the company’s beta value hitting 1.48. At the close
ATAI Life Sciences N.V (NASDAQ:ATAI)’s traded shares stood at 1.23 million during the last session, with the company’s beta value hitting 1.48. At the close
In the last trading session, 3.2 million ATAI Life Sciences N.V (NASDAQ:ATAI) shares changed hands as the company’s beta touched 1.49. With the company’s per
In last trading session, ATAI Life Sciences N.V (NASDAQ:ATAI) saw 3.93 million shares changing hands with its beta currently measuring 1.48. Company’s recent per share
ATAI Life Sciences N.V (NASDAQ:ATAI) has a beta value of 1.48 and has seen 2.79 million shares traded in the recent trading session. The company,
In the last trading session, 3.42 million shares of the ATAI Life Sciences N.V (NASDAQ:ATAI) were traded, and its beta was 1.35. Most recently the
In the last trading session, 7.2 million ATAI Life Sciences N.V (NASDAQ:ATAI) shares changed hands as the company’s beta touched 1.33. With the company’s per
ATAI Life Sciences N.V (NASDAQ:ATAI) has a beta value of 1.22 and has seen 1.26 million shares traded in the last trading session. The company,
During the last session, ATAI Life Sciences N.V (NASDAQ:ATAI)’s traded shares were 1.39 million, with the beta value of the company hitting 1.22. At the
© 2024, Powered by Smart TechOne